AZD8186   Click here for help

GtoPdb Ligand ID: 8527

Synonyms: AZD 8186 | AZD-8186
Compound class: Synthetic organic
Comment: AZD8186 is a selective inhibitor of PI3Kβ- and δ-mediated AKT signalling [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 75.02
Molecular weight 457.18
XLogP 4.78
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES Fc1cc(cc(c1)F)NC(c1cc(cc2c1oc(cc2=O)N1CCOCC1)C(=O)N(C)C)C
Isomeric SMILES Fc1cc(cc(c1)F)N[C@@H](c1cc(cc2c1oc(cc2=O)N1CCOCC1)C(=O)N(C)C)C
InChI InChI=1S/C24H25F2N3O4/c1-14(27-18-11-16(25)10-17(26)12-18)19-8-15(24(31)28(2)3)9-20-21(30)13-22(33-23(19)20)29-4-6-32-7-5-29/h8-14,27H,4-7H2,1-3H3/t14-/m1/s1
No information available.
Summary of Clinical Use Click here for help
AZD8186 in combination with the anti-androgenic drug abiraterone, is being evaluated in Phase 1 clinical trial as a potential treatment for prostate cancer. The two compounds block complementary molecular pathways in prostate cancer, providing synergistic activity. A second Phase 1 study is determining efficacy of AZD8186 plus docetaxel in advanced breast cancer. Click here to link to's full list of AZD8186 trials.